Recently, the structure-based mechanism of prestin electromotive signal amplification was illustrated (Ge et al., 2021), providing a better understanding of the molecular basis of hearing and a crucial guidance for the treatment of hearing impairment. The gene discussed is SLC26A5; the disease is hearing loss disorder.